Details of the Drug

General Information of Drug (ID: DMLRBXM)

• Drug Name: Q-301

Indication

Disease Entry	ICD 11	Status	REF
Atopic dermatitis	EA80	Phase 2	[1]
Hepatitis C virus infection	1E51.1	Phase 2	[2]

• Cross-matching ID: TTD ID: D09QMX
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [2] ClinicalTrials.gov (NCT02426359) Safety and Efficacy Study of Q301 in Moderate to Severe Atopic Dermatitis Patients. U.S. National Institutes of Health.